Dana Bruden

6.6k total citations
83 papers, 2.5k citations indexed

About

Dana Bruden is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Dana Bruden has authored 83 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 29 papers in Hepatology and 21 papers in Infectious Diseases. Recurrent topics in Dana Bruden's work include Respiratory viral infections research (29 papers), Hepatitis C virus research (25 papers) and Hepatitis B Virus Studies (23 papers). Dana Bruden is often cited by papers focused on Respiratory viral infections research (29 papers), Hepatitis C virus research (25 papers) and Hepatitis B Virus Studies (23 papers). Dana Bruden collaborates with scholars based in United States, Canada and Kenya. Dana Bruden's co-authors include Michael G. Bruce, Thomas W. Hennessy, Brian J. McMahon, Lisa Bulkow, Karen Rudolph, Rosalyn Singleton, Debby Hurlburt, Thomas Hennessy, Jay C. Butler and Alisa Reasonover and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Dana Bruden

79 papers receiving 2.4k citations

Peers

Dana Bruden
J Heptonstall United Kingdom
Michael G. Bruce United States
David Speers Australia
Jonathan R. Hibbs United States
J Heptonstall United Kingdom
Dana Bruden
Citations per year, relative to Dana Bruden Dana Bruden (= 1×) peers J Heptonstall

Countries citing papers authored by Dana Bruden

Since Specialization
Citations

This map shows the geographic impact of Dana Bruden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Bruden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Bruden more than expected).

Fields of papers citing papers by Dana Bruden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Bruden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Bruden. The network helps show where Dana Bruden may publish in the future.

Co-authorship network of co-authors of Dana Bruden

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Bruden. A scholar is included among the top collaborators of Dana Bruden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Bruden. Dana Bruden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Steinberg, Jonathan, Sara Bressler, Alisa Reasonover, et al.. (2023). Invasive Pneumococcal Disease and Potential Impact of Pneumococcal Conjugate Vaccines Among Adults, Including Persons Experiencing Homelessness—Alaska, 2011–2020. Clinical Infectious Diseases. 78(1). 172–178. 9 indexed citations
3.
Bressler, Sara, Dana Bruden, Leisha D. Nolen, et al.. (2022). Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–8. 1 indexed citations
4.
Bruce, Michael G., Dana Bruden, Debby Hurlburt, et al.. (2022). Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose. Hepatology. 76(4). 1180–1189. 31 indexed citations
5.
Plumb, Ian D., Prabhu Gounder, Dana Bruden, et al.. (2020). Increasing non-susceptibility to antibiotics within carried pneumococcal serotypes — Alaska, 2008–2015. Vaccine. 38(27). 4273–4280. 4 indexed citations
6.
McMahon, Brian J., Lisa Townshend‐Bulson, Chriss Homan, et al.. (2019). Cascade of Care for Alaska Native People With Chronic Hepatitis C Virus Infection: Statewide Program With High Linkage to Care. Clinical Infectious Diseases. 70(9). 2005–2007. 12 indexed citations
7.
Miernyk, Karen, Dana Bruden, Alan J. Parkinson, et al.. (2019). Human Seroprevalence to 11 Zoonotic Pathogens in the U.S. Arctic, Alaska. Vector-Borne and Zoonotic Diseases. 19(8). 563–575. 16 indexed citations
8.
Nolen, Leisha D., Dana Bruden, Karen Miernyk, et al.. (2018). H. pylori-associated pathologic findings among Alaska native patients. International Journal of Circumpolar Health. 77(1). 1510715–1510715. 9 indexed citations
9.
Mosites, Emily, Karen Miernyk, Jeffrey W. Priest, et al.. (2018). GiardiaandCryptosporidiumantibody prevalence and correlates of exposure among Alaska residents, 2007–2008. Epidemiology and Infection. 146(7). 888–894. 8 indexed citations
11.
Gounder, Prabhu, Dana Bruden, Lisa Townshend‐Bulson, et al.. (2016). Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?. Journal of Clinical Gastroenterology. 52(1). 60–66. 6 indexed citations
12.
McMahon, Brian J., Dana Bruden, Lisa Townshend‐Bulson, et al.. (2016). Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death. Clinical Gastroenterology and Hepatology. 15(3). 431–437.e2. 42 indexed citations
13.
Rudolph, Karen, Irene Martín, Walter Demczuk, et al.. (2016). International circumpolar surveillance interlaboratory quality control program for emm typing of Streptococcus pyogenes, 2011–2015. Diagnostic Microbiology and Infectious Disease. 85(4). 398–400. 3 indexed citations
14.
Bruce, Michael G., Rosalyn Singleton, Lisa Bulkow, et al.. (2015). Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska. Vaccine. 33(38). 4813–4819. 59 indexed citations
15.
Gounder, Prabhu, Michael G. Bruce, Dana Bruden, et al.. (2013). Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae--Alaska, 2008-2012. The Journal of Infectious Diseases. 209(8). 1251–1258. 41 indexed citations
16.
Rudolph, Karen, Michael G. Bruce, Dana Bruden, et al.. (2012). Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986–2009. Diagnostic Microbiology and Infectious Disease. 75(3). 271–276. 9 indexed citations
17.
Stevens, Anne M., et al.. (2010). Methicillin-ResistantStaphylococcus aureusCarriage and Risk Factors for Skin Infections, Southwestern Alaska, USA. Emerging infectious diseases. 16(5). 797–803. 40 indexed citations
18.
McMahon, Brian J., Dana Bruden, Michael G. Bruce, et al.. (2009). Adverse Outcomes in Alaska Natives Who Recovered From or Have Chronic Hepatitis C Infection. Gastroenterology. 138(3). 922–931.e1. 39 indexed citations
19.
Singleton, Rosalyn, Dana Bruden, & Lisa Bulkow. (2007). Respiratory Syncytial Virus Season and Hospitalizations in the Alaskan Yukon-Kuskokwim Delta. The Pediatric Infectious Disease Journal. 26(11). S46–S50. 25 indexed citations
20.
Baggett, Henry C., Thomas W. Hennessy, Richard Leman, et al.. (2003). An Outbreak of Community-Onset Methicillin-ResistantStaphylococcus aureusSkin Infections in Southwestern Alaska. Infection Control and Hospital Epidemiology. 24(6). 397–402. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026